(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 17.02% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.12%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.92%.
Natera's revenue in 2026 is $2,500,925,000.On average, 23 Wall Street analysts forecast NTRA's revenue for 2026 to be $407,447,761,790, with the lowest NTRA revenue forecast at $370,068,547,088, and the highest NTRA revenue forecast at $423,201,453,810. On average, 23 Wall Street analysts forecast NTRA's revenue for 2027 to be $481,776,545,048, with the lowest NTRA revenue forecast at $437,666,207,392, and the highest NTRA revenue forecast at $518,296,467,458.
In 2028, NTRA is forecast to generate $578,590,143,280 in revenue, with the lowest revenue forecast at $532,761,221,040 and the highest revenue forecast at $658,790,757,200.